← Back to all trials
Completed
NCT07757126
Lung Ultrasound With Acute Exacerbation and Stable COPD
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Sex: All
Ages: 40 Years – 75 Years
Healthy volunteers: Yes
Enrollment: 85
Sponsor: Hacettepe University
Location: Munzur University Faculty of Health Sciences Tunceli
Summary
This cross-sectional study aims to compare lung ultrasound findings, functional capacity, and dyspnea among patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), patients with stable COPD, and healthy controls. The study will include approximately 60 participants divided into three groups (acute exacerbation COPD, stable COPD, and healthy controls). Participants will undergo comprehensive assessments including lung ultrasound, pulmonary function tests, the Modified Borg Scale, the Modified Medical Research Council (mMRC) Dyspnea Scale, the 6-Minute Walk Test, the 1-Minute Sit-to-Stand Test, the COPD Assessment Test (CAT), the Charlson Comorbidity Index, and the BODE Index. The primary objective is to determine differences in lung ultrasound abnormalities, particularly B-lines, consolidations, and lung ultrasound scores, and to investigate their relationship with functional capacity and dyspnea severity. The findings are expected to clarify the clinical utility of lung ultrasound as a non-invasive bedside assessment tool for evaluating disease severity and supporting comprehensive management of patients with COPD.
Eligibility Criteria
Inclusion Criteria:
* Acute Exacerbation COPD Group
* Adults aged 40-65 years.
* Diagnosis of chronic obstructive pulmonary disease (COPD) according to GOLD criteria.
* Currently experiencing an acute exacerbation of COPD.
* Able and willing to provide written informed consent.
* Stable COPD Group
* Adults aged 40-75 years.
* Diagnosis of chronic obstructive pulmonary disease (COPD) according to GOLD criteria.
* Clinically stable without an acute exacerbation at the time of assessment.
* Able and willing to provide written informed consent.
* Healthy Control Group
* Adults aged 40-65 years.
* No history of chronic pulmonary disease.
* Able and willing to provide written informed consent.
Exclusion Criteria:
* Presence of cardiovascular, neurological, orthopedic, psychiatric, or other systemic diseases that may affect study assessments.
* Cognitive impairment or psychological conditions preventing completion of study procedures.
* History of thoracic or major surgery that could influence pulmonary function or lung ultrasound findings.
* Pregnancy.
* Inability to perform pulmonary function testing or functional exercise tests.
* Refusal or inability to provide written informed consent.
Source: ClinicalTrials.gov (NCT07757126). StuddyBuddy aggregates publicly available trial information.